Cumberland Pharmaceuticals Inc. (CPIX)
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It also develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases; and a product candidate that is in Phase II clinical trial for cholesterol reducing agent to use in the hospital setting. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.
$18.04M
Mr. A. J. Kazimi MBA
83.00
Nashville, TN
Aug 11, 2009
-1.78
$-0.72
0.70
1.44
-27.45%
-1.74
-0.44
0.69
0.48
1.26
-13.21%
-34.74%
Similar stocks (11)
Ironwood Pharmaceuticals, Inc.
IRWD
Organogenesis Holdings Inc.
ORGO
Alimera Sciences, Inc.
ALIM
Lifecore Biomedical, Inc.
LFCR
Eagle Pharmaceuticals, Inc.
EGRX
Guardion Health Sciences, Inc.
GHSI
Agile Therapeutics, Inc.
AGRX
Biofrontera Inc.
BFRI
Evoke Pharma, Inc.
EVOK
Shuttle Pharmaceuticals Holdings, Inc.
SHPH
Petros Pharmaceuticals, Inc.
PTPI
ETF Exposure (12)
Dimensional U.S. Targeted Value ETF
DFAT
4.9995e-4%
Dimensional U.S. Small Cap ETF
DFAS
2.8534999999999997e-4%
Dimensional US Marketwide Value ETF
DFUV
2.7449e-4%
Dimensional U.S. Core Equity 2 ETF
DFAC
1.617e-5%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (11)
Ironwood Pharmaceuticals, Inc.
IRWD
Organogenesis Holdings Inc.
ORGO
Alimera Sciences, Inc.
ALIM
Lifecore Biomedical, Inc.
LFCR
Eagle Pharmaceuticals, Inc.
EGRX
Guardion Health Sciences, Inc.
GHSI
Agile Therapeutics, Inc.
AGRX
Biofrontera Inc.
BFRI
Evoke Pharma, Inc.
EVOK
Shuttle Pharmaceuticals Holdings, Inc.
SHPH
Petros Pharmaceuticals, Inc.
PTPI
ETF Exposure (12)
Dimensional U.S. Targeted Value ETF
DFAT
4.9995e-4%
Dimensional U.S. Small Cap ETF
DFAS
2.8534999999999997e-4%
Dimensional US Marketwide Value ETF
DFUV
2.7449e-4%
Dimensional U.S. Core Equity 2 ETF
DFAC
1.617e-5%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%